Article: Linking genomics with proteomics to accelerate the search for drug targets
Posted: 30 March 2021 | Olink | No comments yet
Several recent studies highlight the promise of combining genomics and proteomics to uncover new, robust drug targets.
Research summary article of three recently published research studies that highlight the importance of linking genetic and protein expression data in the context of disease phenotypes in order to identify actionable protein targets for drug development.
Related content from this organisation
Related topics
Biomarkers, Biopharmaceuticals, Disease Research, Proteomics, Targets
Related organisations
Olink